Table 3.

Demographic characteristics and anatomical follow-up parameters of Group 2 (management with only rEMS).

Patient no	Genetic mutation	Eye	Horizontal EZW		Vertical EZW		FAF field
			Time0	Time1	Time0	Time1	Time0	Time1
1	RHO	R	6.38	6.17	6.32	6.16	35.8	34.0
		L	6.44	6.24	6.40	6.19	36.2	34.1
2	PCARE	R	2.89	2.64	2.87	2.61	8.1	6.6
		L	2.86	2.58	2.85	2.57	8.0	6.5
3	RPGR	R	1.84	1.04	1.79	1.02	2.9	1.2
		L	1.81	1.09	1.79	1.07	3.1	1.3
4	USH2A	R	4.97	4.32	4.94	4.30	25.9	25.4
		L	5.01	4.79	5.00	4.78	26.1	25.7
5	USH2A	R	4.63	4.39	4.57	4.29	22.2	20.8
		L	4.66	4.38	4.81	4.52	23.6	22.0
6	PDE6B	R	5.94	5.21	5.87	5.12	32.2	27.5
		L	6.21	5.43	6.17	5.40	32.8	27.8
7	RP1	R	3.21	2.86	3.19	2.84	10.1	9.0
		L	3.24	2.88	3.22	2.87	10.4	9.3
8	BBS1	R	2.47	2.27	2.51	2.31	6.2	5.7
		L	2.46	2.26	2.50	2.30	6.1	5.6
9	RHO	R	4.89	4.60	4.87	4.57	17.1	16.6
		L	4.82	4.53	4.81	4.52	16.8	15.8
10	USH2A	R	5.11	4.80	5.09	4.78	26.8	25.2
		L	5.16	4.85	5.12	4.80	27.1	25.5
11	BBS2	R	3.26	2.90	3.15	2.80	10.2	9.1
		L	3.24	2.89	3.21	2.86	10.3	9.2
12	RHO	R	4.51	4.34	4.50	4.34	20.1	19.2
		L	4.60	4.38	4.57	4.36	21.9	21.0
13	RHO	R	5.26	5.01	5.54	5.22	28.2	26.5
		L	5.19	4.94	5.27	4.95	27.4	25.7
14	USH2A	R	3.96	3.70	3.94	3.68	15.2	14.3
		L	3.90	3.66	3.90	3.67	15.0	14.1
15	EYS	R	2.55	2.18	2.56	2.19	6.9	5.1
		L	2.61	2.22	2.71	2.32	7.0	5.2
16	RHO	R	4.97	4.67	4.96	4.66	25.1	23.4
		L	4.86	4.57	4.89	4.59	24.0	22.4

Time0 (baseline): just before the Magnovision application.

Time1: 36th month of weekly rEMS sessions.

Abbreviations: EZW, ellipsoid zone width (mm); FAF, fundus autofluorescence (mm²); rEMS, repetitive electromagnetic stimulation.